Related Experiment Video
Updated: Sep 19, 2025

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
Published on: September 16, 2012
Whole blood stability in bioanalytical method validation: updated recommendations from the European Bioanalysis Forum
Lee Goodwin1, Jörg Faber2, Kristina H Holmberg3
1Labcorp, Bioanalytical Services, Harrogate, UK.
None:
This paper discusses the updated recommendations from the European Bioanalysis Forum on whole blood stability testing in bioanalytical method validation. The recommendations are based on EBF community feedback on the ICH M10 guidelines and associated training materials. The ICH M10 guidelines highlight the importance of assessing analyte stability throughout the lifecycle of the sample, including in whole blood, immediately after collection, to ensure that the analyte concentration in the tested sample accurately reflects the concentration at the time of collection. Aspects considered in these recommendations are the definition of fresh blood, equilibration times, assay type and how the experiments can be conducted to align with the 3Rs principles.
More Related Videos
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
08:44Dried Blood and Serum Spots As A Useful Tool for Sample Storage to Evaluate Cancer Biomarkers
Published on: June 11, 2018
Related Concept Videos
Data Validation
Key parameters for method validation include:
Blood Studies I: ABG and VBG
Arterial Blood Gas (ABG)
Arterial Blood Gas (ABG) studies are crucial for assessing the lungs' ability to supply oxygen and remove carbon dioxide, reflecting the patient's ventilation status. They also help understand the kidneys' capacity to...